title: Whole brain radiation therapy in management of brain metastasis: results and prognostic factors.
abstract: OBJECTIVE
  To evaluate the prognostic factors associated with overall survival in patients with brain metastasis treated with whole brain radiotherapy (WBRT) and estimate the potential improvement in survival for patients with brain metastases, stratified by the Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis (RPA) class.
  
  
  METHODS
  From January 1996 to December 2000, 270 medical records of patients with diagnosis of brain metastasis, who received WBRT in the Hospital do Cancer Sao Paulo A.C. Camargo in the period, were analyzed. The surgery followed by WBRT was used in 15% of patients and 85% of others patients were submitted at WBRT alone; in this cohort 134 patients (50%) received the fractionation schedule of 30 Gy in 10 fractions. The most common primary tumor type was breast (33%) followed by lung (29%), and solitary brain metastasis was present in 38.1% of patients. The prognostic factors evaluated for overall survival were: gender, age, Karnofsky Performance Status (KPS), number of lesions, localization of lesions, primary tumor site, surgery, chemotherapy, absence extracranial disease, RPA class and radiation doses and fractionation.
  
  
  RESULTS
  The OS in 1, 2 and 3 years was 25.1%, 10.4% and 4.3% respectively, and the median survival time was 4.6 months. The median survival time in months according to RPA class after WBRT was: 6.2 class I, 4.2 class II and 3.0 class III (p < 0.0001). In univariate analysis, the significant prognostic factors associated with better survival were: KPS higher than 70 (p < 0.0001), neurosurgery (p < 0.0001) and solitary brain metastasis (p = 0.009). In multivariate analysis, KPS higher than 70 (p < 0.001) and neurosurgery (p = 0.001) maintained positively associated with the survival.
  
  
  CONCLUSIONS
  In this series, the patients with higher perform status, RPA class I, and treated with surgery followed by whole brain radiotherapy had better survival. This data suggest that patients with cancer and a single metastasis to the brain may be treated effectively with surgical resection plus radiotherapy. The different radiotherapy doses and fractionation schedules did not altered survival.
authors.affiliation: Department of Radiation Oncology Hospital do Cancer, Sao Paulo, Brazil. elisaito@yahoo.com.br
authors.forename: Elisa Y
authors.initials: EY
authors.lastname: Saito
authors.forename: Gustavo A
authors.initials: GA
authors.lastname: Viani
authors.forename: Robson
authors.initials: R
authors.lastname: Ferrigno
authors.forename: Ricardo A
authors.initials: RA
authors.lastname: Nakamura
authors.forename: Paulo E
authors.initials: PE
authors.lastname: Novaes
authors.forename: Cassio A
authors.initials: CA
authors.lastname: Pellizzon
authors.forename: Ricardo C
authors.initials: RC
authors.lastname: Fogaroli
authors.forename: Maria A
authors.initials: MA
authors.lastname: Conte
authors.forename: Joao V
authors.initials: JV
authors.lastname: Salvajoli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D015331:Cohort Studies; D019583:Dose Fractionation, Radiation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011878:Radiotherapy / Q000379:methods*; D012189:Retrospective Studies; D016896:Treatment Outcome